2.63
5.05%
-0.14
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
100.00%
-
|
0.0186 | 0.0373 | 0.0369 | 0.0364 |
Operating Expenses
|
198.16%
3.8686
|
1.2975 | 3.6374 | 3.9522 | 5.7012 |
Benefits Costs and Expenses |
0.8217
|
- | - | - | - |
Costs And Expenses |
198.16%
3.8686
|
1.2975 | 3.6374 | 3.9522 | 5.7012 |
Operating Income/Loss |
202.50%
-3.8686
|
-1.2789 | -3.6001 | -3.9153 | -5.6648 |
Income/Loss From Continuing Operations Before Tax |
131.27%
0.3654
|
-1.1685 | 0.0373 | 0.0369 | -5.6671 |
Income/Loss From Continuing Operations After Tax |
131.27%
0.3654
|
-1.1685 | -3.6767 | -3.9467 | -5.6671 |
Net Income/Loss
|
131.27%
0.3654
|
-1.1685 | -3.6767 | -3.9467 | -5.6671 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
21.59%
4.6177
|
3.7978 | -16.53 | 29.38 | 16.51 |
Diluted Average Shares |
28.65%
4.8858
|
3.7978 | -16.53 | 29.38 | - |
Basic Earnings Per Share |
125.81%
0.08
|
-0.31 | -17.28 | -0.13 | -0.34 |
Diluted Earnings Per Share |
122.58%
0.07
|
-0.31 | -17.28 | -0.13 | - |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):